Clearside Biomedical Inc (CLSD) Stock offers help to cash-strapped investors
Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]
Top-line Growth is Likely to Be Driven by Clearside Biomedical Inc (CLSD) Stock
Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]
Analysts Estimated Revenue of $580k in the current quarter for Clearside Biomedical Inc (NASDAQ:CLSD) Stock
Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]
Analyzing Clearside Biomedical Inc’s (CLSD) Stock earnings per share and revenue
Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]
The Technical Story of Clearside Biomedical Inc (CLSD) Stock
Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]